Learn more

SHANGHAI HYCHARM INC

Overview
  • Total Patents
    12
  • GoodIP Patent Rank
    146,724
  • Filing trend
    ⇩ 100.0%
About

SHANGHAI HYCHARM INC has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in China, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are SHANGHAI BIO ROAD GENE DEV LTD, ULTIMOVACS AS and APPLIED MOLECULAR TRANSP INC.

Patent filings in countries

World map showing SHANGHAI HYCHARM INCs patent filings in countries

Patent filings per year

Chart showing SHANGHAI HYCHARM INCs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Rongxiu Li 8
#2 Li Deng 8
#3 Conghao Zhong 8
#4 Zhang Li 7
#5 Li Zhang 7
#6 Shulin Zhang 7
#7 Aizhang Xu 7
#8 Xiaohai Gong 7
#9 Chao Cheng 7
#10 Rongsong Li 7

Latest patents

Publication Filing date Title
CN109381704A The immunocyte and vaccine of plasma thromboplastin antecedent target and the purposes for treating metabolic syndrome
CN108144055A Chemical coupling product of TNF-α mutain and formalin-inactivated PD carrier proteins and preparation method thereof
CN108126195A Chemical coupling product of TNF-α mutain and formalin-inactivated TT carrier proteins and preparation method thereof
CN108126193A TNF-α mutain and the product of carrier protein CRM197 chemical couplings and preparation method thereof
CN108126197A Chemical coupling product of TNF-α mutain and KLH, CTB, OVA, BSA and preparation method thereof
CN108126196A Chemical coupling product of TNF-α mutain and formalin-inactivated OMP carrier proteins and preparation method thereof
CN108126194A Chemical coupling product of TNF-α mutain and formalin-inactivated DT carrier proteins and preparation method thereof
CN108117598A TNF-α and its mutain and the vaccine preparation method of carrier protein DTT difference connection modes
EP2998322A1 Epitope vaccine for low immunogenic protein and preparing method and usage thereof